跳转至内容
Merck
CN
  • Heterogeneity in VEGF Receptor-2 Mobility and Organization on the Endothelial Cell Surface Leads to Diverse Models of Activation by VEGF.

Heterogeneity in VEGF Receptor-2 Mobility and Organization on the Endothelial Cell Surface Leads to Diverse Models of Activation by VEGF.

Cell reports (2020-10-01)
Bruno da Rocha-Azevedo, Sungsoo Lee, Aparajita Dasgupta, Anthony R Vega, Luciana R de Oliveira, Tae Kim, Mark Kittisopikul, Zachariah A Malik, Khuloud Jaqaman
摘要

The dynamic nanoscale organization of cell surface receptors plays an important role in signaling. We determine this organization and its relation to activation of VEGF receptor-2 (VEGFR-2), a critical receptor tyrosine kinase in endothelial cells (ECs), by combining single-molecule imaging of endogenous VEGFR-2 in live ECs with multiscale computational analysis. We find that surface VEGFR-2 can be mobile or exhibit restricted mobility and be monomeric or non-monomeric, with a complex interplay between the two. This basal heterogeneity results in heterogeneity in the sequence of steps leading to VEGFR-2 activation by VEGF. Specifically, we find that VEGF can bind to monomeric and non-monomeric VEGFR-2 and that, when binding to monomeric VEGFR-2, its effect on dimerization depends on the mobility of VEGFR-2. Our study highlights the dynamic and heterogeneous nature of cell surface receptor organization and the need for multiscale, single-molecule-based analysis to determine its relationship to receptor activation and signaling.

材料
货号
品牌
产品描述

Sigma-Aldrich
Atto 488 蛋白标记试剂盒, BioReagent, suitable for fluorescence
Sigma-Aldrich
单克隆抗肌动蛋白抗体 小鼠抗, clone AC-40, ascites fluid
Millipore
ReBlot Plus试剂盒
Sigma-Aldrich
VEGFR Tyrosine Kinase Inhibitor VI, AAL-993, The VEGFR Tyrosine Kinse Inhibitor VI, ALL-993, also referenced under CAS 269390-77-4, controls the biological activity of VEGFR Tyrosine Kinase. This small molecule/inhibitor is primarily used for Cancer applications.